We conducted an analysis of PKD mRNA expression levels in breast cancer using the TCGA database that revealed a decrease in PKD1 expression and an increase in PKD3 expression, whereas PKD2 levels are unchanged in basal-like breast cancer compared with normal tissue (Figures 3A–C). This evidence concerns the gene PRKD1 and breast carcinoma.